IQVIA director granted 211 deferred share units

IQVIA Holdings director Jim Fasano reported an acquisition of deferred share units tied to company stock.

Rhea-AI Filing Summary

IQVIA Holdings director Jim Fasano reported an acquisition of deferred share units tied to company stock. On 02/09/2026, he received a grant of 211 deferred shares at a reported price of $192.67 per unit, increasing his directly held deferred shares to 4,274.

Each deferred share converts into one share of IQVIA common stock upon settlement. Under the company’s Non-Employee Director Deferral Plan, these units generally settle when he ceases to be a director, upon a change in control of the company, or upon his death, and they have no expiration date.

Insider Trade Summary

Grant/Award: 211 shares

Grant/Award 1 txn

Insider Fasano Jim

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares	211	$192.67	$41K

Holdings After Transaction: Deferred Shares — 4,274 contracts (Direct)

Footnotes (1)

1. F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IQVIA (IQV) director Jim Fasano report?

Jim Fasano reported receiving 211 deferred shares linked to IQVIA common stock. The grant, dated 02/09/2026, is a deferred share award that increases his directly held deferred share balance to 4,274 units under the company’s Non-Employee Director Deferral Plan.

How many IQVIA (IQV) deferred shares does Jim Fasano hold after this Form 4?

After the reported transaction, Jim Fasano beneficially owns 4,274 deferred shares. This total includes the new grant of 211 deferred shares reported for 02/09/2026, all held as direct ownership under IQVIA’s Non-Employee Director Deferral Plan framework.

What is the conversion ratio for Jim Fasano’s IQVIA (IQV) deferred shares?

Each deferred share held by Jim Fasano converts into one share of IQVIA common stock. The filing specifies a one-for-one conversion upon settlement, meaning 211 deferred shares would entitle him to 211 common shares when settlement conditions are met.

When do Jim Fasano’s IQVIA (IQV) deferred shares become settleable?

The deferred shares become settleable when Jim Fasano ceases to be a director, upon a change in control of IQVIA, or upon his death. These conditions are outlined in IQVIA’s Non-Employee Director Deferral Plan that governs the timing of settlement.

Do Jim Fasano’s IQVIA (IQV) deferred shares have an expiration date?

The deferred shares reported in the filing have no expiry date. According to the disclosure, they remain outstanding until settlement, which occurs upon specified events such as his departure from the board, a change in control, or his death.

What price is associated with Jim Fasano’s new IQVIA (IQV) deferred share grant?

The filing lists a price of $192.67 for the deferred share award granted on 02/09/2026. This figure is recorded as the price of the derivative security for the 211 deferred shares reported in the Form 4 transaction table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 05:06 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fasano Jim

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	02/09/2026		A		211		(1)	(1)	Common Stock	211	$192.67	4,274	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

	/s/ Matthew Gilmartin, Attorney-in-Fact for Jim Fasano	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.